Anti-filarial antibodies are sensitive indicators of lymphatic filariasis transmission and enable identification of high-risk populations and hotspots

•Antibodies (Abs) were a more sensitive indicator of transmission than antigen (Ag).•Higher seroprevalence of Bm14 Ab, Bm33 Ab, and Wb123 Ab compared to Ag was found.•Ab seroprevalence was significantly higher among older males in suspected hotspots.•Significant clustering of Ab seropositivity was s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of infectious diseases 2024-10, Vol.147, p.107194-None, Article 107194
Hauptverfasser: Lawford, Harriet, Mayfield, Helen, Sam, Filipina Amosa-Lei, Viali, Satupaitea, Kamu, Tito, Cooley, Gretchen, Simon, Ashley, Martin, Diana, Lau, Colleen L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Antibodies (Abs) were a more sensitive indicator of transmission than antigen (Ag).•Higher seroprevalence of Bm14 Ab, Bm33 Ab, and Wb123 Ab compared to Ag was found.•Ab seroprevalence was significantly higher among older males in suspected hotspots.•Significant clustering of Ab seropositivity was seen at the household-level.•Further research is needed to define Ab thresholds for active versus past infection. Circulating filarial antigen (Ag) is used by elimination programs to monitor lymphatic filariasis (LF) transmission; however, antifilarial antibodies (Ab) may be more sensitive than Ag for detecting LF. Our objectives were to describe Ab seroprevalence, identify risk factors for Ab seropositivity, investigate age-specific associations between Ag and Ab, and evaluate geographic clustering of seropositivity. Community-based serosurveys of participants aged ≥5 years were conducted in 35 primary sampling units (PSUs). Ag-positivity was detected using Alere™ Filariasis Test Strips and Ab-seropositivity using multiplex bead assays. Seroprevalence was adjusted for study design. Of 3795 participants (range:5-90 years), adjusted prevalence for Ag, Bm14 Ab, Wb123 Ab, and Bm33 Ab were 3.7% (n=117), 20.3% (n=583), 32.2% (n=987), and 51.0% (n=1659), respectively. Male sex, older age, and residents of suspected hotspots had higher odds of seropositivity to all seromarkers. Seroprevalence was lower in 5-9-year-olds vs ≥10-year-olds (P
ISSN:1201-9712
1878-3511
1878-3511
DOI:10.1016/j.ijid.2024.107194